Enlivex successfully completed a $21 million capital raise through debt financing, channeling proceeds toward digital asset accumulation and pharmaceutical development. The biotechnology firm significantly expanded its holdings in RAIN tokens while securing extended options for future acquisitions.
Source: Read the original article
